Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SURMOUNT-ADOLESCENTS tirzepatide versus placebo in adolescents with obesity or overweight with comorbidity
MOH_2023-08-27_012858Phase 3Active, not recruiting
- Sponsor
- Eli Lilly and Company
- Start
- Jun 2023
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in obesity and Overweight comparing Tirzepatide with Placebo (2 arms). Started Jun 2023; status: active, not recruiting.
02
Drugs
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on MOH_2023-08-27_012858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2023-08-27_012858.